National Research Corporation (NRC)

NASDAQ:
NRC
| Latest update: Mar 1, 2026, 6:58 PM

Stock events for National Research Corp. (NRC)

In August 2025, Shane Harrison was appointed as Executive Vice President and Chief Financial Officer. In November 2025, David Burik was appointed as Executive Vice President, Strategic Insights. In Q3 2025, NRC Health reported $34.6 million in revenue, a 2% sequential increase, and an 11% year-over-year increase in Adjusted EBITDA to $10.9 million, with TRCV increasing 8% to $141.7 million. In December 2025, NRC Health partnered with Mosaic Life Care. In February 2026, Q4 2025 results showed revenue of $35.2 million (down 5% year-over-year) and full-year revenue of $137.4 million (down 4%), leading to a stock drop, despite an 86% year-over-year increase in new sales and TRCV increasing 8% year-over-year to $144.1 million.

Demand Seasonality affecting National Research Corp.’s stock price

National Research Corp. operates on a subscription-based model, with the majority of its revenue being recurring and TRCV showing consistent growth. The subscription-based nature and focus on long-term contracts suggest a relatively stable demand profile rather than significant seasonality.

Overview of National Research Corp.’s business

NRC Health operates as a healthcare intelligence firm, providing analytics and insights to healthcare organizations, focusing on improving patient and employee experiences through its SaaS business model. The company offers Patient & Family Experience Solutions for real-time feedback and CAHPS compliance, Market Insights & Brand Loyalty solutions for market share analysis and brand growth, Reputation Solutions for managing public image, Employee Experience Solutions for fostering engagement, Consumer Experience Solutions for capturing feedback, Huey AI for intelligent analysis, and Governance Solutions for healthcare boards.

NRC’s Geographic footprint

National Research Corp. primarily serves clients across the United States and Canada, with the majority of its revenue coming from the United States. The company is headquartered in Lincoln, Nebraska.

NRC Corporate Image Assessment

NRC Health has maintained a strong brand reputation, receiving the "Best in KLAS Award for Healthcare Experience Management" in 2025. The company's tagline, "Human Understanding®," is a registered trademark and reflects its use of advanced technology, including AI, to collect and analyze feedback in a human-centered way.

Ownership

National Research Corp.'s ownership is primarily held by institutional investors (51.54%) and company insiders (46.42%), with retail/public investors accounting for 2.04%. Major institutional shareholders include Kayne Anderson Rudnick Investment Management Llc, PSGAX - Virtus KAR Small-Cap Growth Fund Class A, BlackRock, Inc., Morgan Stanley, Vanguard Group Inc, Dimensional Fund Advisors Lp, Geode Capital Management, Llc, QV Investors Inc., and Renaissance Technologies Llc. Property Trust Common is the largest individual shareholder, owning 37.79% of the company.

Expert AI

Show me the sentiment for National Research Corp.
What's the latest sentiment for National Research Corp.?

Price Chart

$13.41

0.22%
(1 month)

Top Shareholders

Virtus Investment Partners, Inc.
11.73%
BlackRock, Inc.
4.44%
Morgan Stanley
4.43%
The Vanguard Group, Inc.
3.73%
Dimensional Holdings, Inc.
2.18%
Geode Holdings Trust
1.69%
QV Investors, Inc.
1.68%
Renaissance Technologies Holdings Corp.
1.55%

Trade Ideas for NRC

Today

Sentiment for NRC

News
Social

Buzz Talk for NRC

Today

Social Media

FAQ

What is the current stock price of National Research Corp.?

As of the latest update, National Research Corp.'s stock is trading at $13.41 per share.

What’s happening with National Research Corp. stock today?

Today, National Research Corp. stock is down by -0.22%, possibly due to news.

What is the market sentiment around National Research Corp. stock?

Current sentiment around National Research Corp. stock is negative, based on recent news, trading volume, and analyst opinions.

Is National Research Corp.'s stock price growing?

Over the past month, National Research Corp.'s stock price has decreased by -0.22%.

How can I buy National Research Corp. stock?

You can buy National Research Corp. stock through any brokerage platform, such as e.g., Robinhood, Fidelity, E*TRADE, by searching for the ticker symbol NRC

Who are the major shareholders of National Research Corp. stock?

Major shareholders of National Research Corp. include institutions such as Virtus Investment Partners, Inc. (11.73%), BlackRock, Inc. (4.44%), Morgan Stanley (4.43%) ... , according to the latest filings.